apl. Prof. Dr. Peter Goebell

Medizinische Fakultät Urologische Klinik

Intersektorale Schnittstelle – eine Chance für Studien zur Versorgungsforschung? (2020) Goebell P Journal article, Review article 99mTc-MIP-1404 SPECT/CT for Assessment of Whole-Body Tumor Burden and Treatment Response in Patients With Biochemical Recurrence of Prostate Cancer (2020) Schmidkonz C, Götz TI, Atzinger A, Ritt P, Prante O, Kuwert T, Bäuerle T, et al. Journal article Re: Aurélie Kamoun, Aurélien de Reyniès, Yves Allory, et al. A Consensus Molecular Classification of Muscle-invasive Bladder Cancer. Eur Urol 2020;77:420–33: A Statement from the International Bladder Cancer Network (2020) Williams SB, Black PC, Dyrskjøt L, Seiler R, Schmitz-Dräger B, Nawroth R, Todenhöfer T, et al. Journal article, Letter Sarcopenia Assessments as Predictors of Overall Survival in Patients with Metastatic Renal Cell Carcinoma (2020) Kuemmerl L, Lesyuk W, Goebell P, Kahlmeyer A Conference contribution Zertifiziertes Weiterbildungscurriculum für die Facharztweiterbildung in Urologie der Deutschen Gesellschaft für Urologie gemäß der Musterweiterbildungsordnung 2018 (Fassung vom 20.09.2019) (2020) Michel MS, Himmler M, Necknig U, Kriegmair M, Speck T, Fichtner J, Steffens J, et al. Journal article First-line pazopanib in intermediate- and poor-risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial (2020) Staehler M, Panic A, Goebell P, Merling M, Potthoff K, Herrmann E, de Geeter P, et al. Journal article Toward noninvasive follow-up of low-risk bladder cancer – Rationale and concept of the UroFollow trial (2020) Benderska-Söder N, Hovanec J, Pesch B, Goebell P, Roghmann F, Noldus J, Rabinovich J, et al. Journal article, Review article Advanced renal cell carcinoma: First results from the prospective research platform CARAT for patients with mRCC in Germany (2019) Goebell P, Mueller L, Gruellich C, Reichert D, Boegemann M, Doerfel S, Von Der Heyde E, et al. Conference contribution Leitlinienadhärenz (2019) Krege S, Goebell P Journal article Expression of PD-1 and CTLA-4 Are Negative Prognostic Markers in Renal Cell Carcinoma (2019) Kahlmeyer A, Stoehr C, Hartmann A, Goebell P, Wullich B, Wach S, Taubert H, Erlmeier F Journal article